Back to search results

Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

This study is looking at whether a special program can help young people with cancer (ages 15-24) take their oral cancer medications as prescribed. You would either participate in a "Tailored Program" with a coach over 4 sessions, or a "Feedback Program" where you receive weekly text messages. Researchers want to see if the Tailored Program helps you take your medicine more consistently, improves your quality of life, and reduces how often you need healthcare. The study is currently unclear about its recruitment status and aims to enroll up to 160 participants.

Study design
This is a randomized clinical trial comparing two programs for up to 160 adolescents and young adults with cancer.
What's involved
You would use an electronic pill bottle for several weeks, complete questionnaires, and then participate in either 4 coaching sessions or receive weekly text messages. You would continue using the electronic monitor until about a month after your program ends.
Compensation
Not stated in the trial record.
Follow-up
You would complete questionnaires at post-treatment and again about 6 months later.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07223463

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

Not Yet Recruiting
NAAges 15–24InterventionalTreatment
Children's Hospital Medical Center, Cincinnati
~160 participants
Updated 2026-06-24 on ClinicalTrials.gov
What's tested:Tailored ProgramFeedback Program (Uniform Standard of Care)

At a glance

Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Medication Adherence
Measured over The 1-month period following the completion of one of the study programs.

Conditions

Cancer
Medication Adherence

Explore related trials

Malignant Neoplasm

Where it's being run

4 sites across 4 states
Kansas1
New York1
Ohio1
Washington1

Study leadership

  • Meghan E. McGrady, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital Medical Center, Cincinnati

Who to contact

Meghan E. McGrady, PhD
[email protected]
513-803-8044
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient is 15.00 to 24.99 years of age
Patient is diagnosed with cancer
Patient is prescribed an oral anticancer/antitumor agent or prophylaxis

Exclusion

Patient is not fluent in English
Patient evidences significant cognitive deficits
Patient's medical status or treatment precludes participation
Patient enrolled on a medical trial requiring medication storage in a trial-provided container
Patient demonstrates greater than or equal to 95% adherence during run-in period
Patient declines to use or has difficulty using electronic adherence monitoring device during run-in

What this trial measures

  • Medication AdherenceThe 1-month period following the completion of one of the study programs.

    Each participant will be given an electronic adherence monitoring device to store their medication. An electronic adherence monitoring device is a pill bottle or box with an embedded computer chip. The computer chip records each time the device is opened. These device openings, or actuations, will be compared with the patient's prescribed medication regimen to compute their adherence (defined as the percentage of doses taken as prescribed).